[go: up one dir, main page]

ZA200710799B - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide - Google Patents

Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide

Info

Publication number
ZA200710799B
ZA200710799B ZA200710799A ZA200710799A ZA200710799B ZA 200710799 B ZA200710799 B ZA 200710799B ZA 200710799 A ZA200710799 A ZA 200710799A ZA 200710799 A ZA200710799 A ZA 200710799A ZA 200710799 B ZA200710799 B ZA 200710799B
Authority
ZA
South Africa
Prior art keywords
methyl
ylamino
trifluoromethylphenyl
benzamide
imidazol
Prior art date
Application number
ZA200710799A
Inventor
Paul W Manley
Shieh Wen-Chung
Sutton Paul Allen
Piotr H Karpinski
Wu Raeann
Monnier Stephanie
Brozio Joerg
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39859562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200710799(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200710799B publication Critical patent/ZA200710799B/en

Links

ZA200710799A 2005-07-20 2007-12-12 Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide ZA200710799B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70140505P 2005-07-20 2005-07-20

Publications (1)

Publication Number Publication Date
ZA200710799B true ZA200710799B (en) 2008-11-26

Family

ID=39859562

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200710799A ZA200710799B (en) 2005-07-20 2007-12-12 Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide

Country Status (2)

Country Link
CN (1) CN101228150B (en)
ZA (1) ZA200710799B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2262793T3 (en) * 2008-11-05 2013-01-31 Teva Pharma Nilotinib hci crystalline forms
AR086913A1 (en) * 2011-06-14 2014-01-29 Novartis Ag 4-METIL-3 - [[4- (3-PIRIDINIL) -2-PIRIMIDINIL] -AMINO] -N- [5- (4-METHYL-1H-IMIDAZOL-1-IL) -3- (TRIFLUORO-METIL) -FENIL] -BENZAMIDA AMORFA, FORM OF DOSAGE THAT CONTAINS AND METHOD TO PREPARE
CN106496193A (en) * 2016-09-13 2017-03-15 福格森（武汉）生物科技股份有限公司 A kind of preparation method of high-purity nilotinib
CN113214225B (en) * 2020-01-21 2023-12-22 江苏希迪制药有限公司 Method for preparing nilotinib Shan Yansuan salt dihydrate crystal form A
CN113788817A (en) * 2021-09-27 2021-12-14 南京海润医药有限公司 Nilotinib semi-hydrochloride monohydrate crystal form and preparation method thereof

Also Published As

Publication number Publication date
CN101228150B (en) 2014-10-15
CN101228150A (en) 2008-07-23

Similar Documents

Publication Publication Date Title
IL214659A0 (en) Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
IL187787A0 (en) Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
IL180546A0 (en) Novel piperidine derivative for the treatment of depression
IL183380A0 (en) Crystalline forms of linezolid intermediate
ZA200710799B (en) Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
ZA200903981B (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethyl-benzamide
ZA200710457B (en) Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoro-methyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
SI1814858T1 (en) Novel crystalline forms of nelfinavir mesylate
GB0522066D0 (en) Timing controller
GB0703687D0 (en) Novel crystalline forms of 6alpha, 9alpha-difluoro-11beta hydroxy-16al-pha-methyl-3-oxo-17alpha-propionyloxy-androsta-1, 4-diene-17beta-carbyoxylic acid
GB2426841B (en) Memory controller
GB0519275D0 (en) Manufacture of Ifenprodil
GB0512717D0 (en) Mouth piece compensation
GB0506135D0 (en) Controlling use of content
ZA200800245B (en) JNK inhibitors for the treatment of endometriosis
GB0407290D0 (en) Temperature controlled matress